ArticleBMC infectious diseases2025
Molecular epidemiology of viral enteric in children in Hangzhou.
Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundViral diarrhea is a major global health burden in children. The implementation of unprecedented non-pharmaceutical interventions (NPIs) during the COVID-19 pandemic, including lockdowns, travel restrictions, school closures, enhanced hand hygiene, and mask-wearing, significantly altered the transmission dynamics of many infectious diseases globally. These measures, primarily targeting respiratory pathogens like SARS-CoV-2, were also anticipated to impact the circulation of enteric viruses, which often spread through the fecal-oral route or via contaminated surfaces and aerosols. However, the extent and nature of this impact on the prevalence, seasonality, and genotype distribution of major pediatric enteric viruses including rotavirus (RV), norovirus (NV), adenovirus (ADV), astrovirus (ASV), and sapovirus (SAV) are key pathogens, their molecular epidemiology during the COVID-19 Pandemic remains poorly characterized. This study aimed to delineate the prevalence, genotype distribution, and genetic features of eight enteric viruses in children with acute diarrhea in Hangzhou, China, from March 2019 to December 2020, encompassing phases before and after COVID-19 emergence.
methodsA hospital-based cross-sectional study analyzed 1,510 stool samples from children with acute diarrhea. Eight viruses (RVA, RVB, RVC, NV GI/GII, ADV, ASV, SAV) were detected using qRT-PCR. Positive samples underwent targeted gene sequencing followed by phylogenetic analysis and amino acid mutation screening against reference strains.
resultsEnteric viruses were detected in 33.38% (504/1,510) of samples. NV GII dominated (48.02%, 242/504), with GII.4 as the predominant genotype (84.62%, 88/104). Temporal shifts were observed: for ASV, HAstV-1 replaced HAstV-5 post-2020, and RV G9 persisted as the dominant genotype (47.06%, 8/17) throughout the study period. ADV 41 remained prevalent (97.37%, 37/38), while SAV exclusively showed GI.1 strains. All amino acid mutations matched known variants.
conclusionThis study offers the first molecular epidemiology data on eight enteric viruses in Hangzhou during a period overlapping with COVID-19. The observed genotype shifts, which highlights the need for targeted surveillance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.